Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

Description

This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).

Conditions

Preeclampsia Postpartum

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).

Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

Condition
Preeclampsia Postpartum
Intervention / Treatment

-

Contacts and Locations

Chicago

University of Chicago Hospital, Chicago, Illinois, United States, 60637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adults between 18 and 45 years of age
  • 2. African American
  • 3. \>120/80 BP at the time of their 6-month visit in the PARENT study
  • 4. Diagnosed with preeclampsia
  • 5. Initially presented to University of Chicago Medical Center (UCMC) for a Singleton Gestation Delivery
  • 6. Completed the 6 month visit in the PARENT study
  • 1. Those who cannot provide consent
  • 2. patients with preexisting cardiomyopathy, ischemic or valvular heart disease, pulmonary disease, diabetes mellitus, chronic kidney disease, multiple gestations,
  • 3. Unable to operate the RPM tablet device

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Chicago,

Sajid H Shahul, MD PHD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

2025-12-31